Effects of empagliflozin on cardio-renal interaction in heart failure with reduced ejection fraction: results from in-vivo experiments and the CINNAMON-study
Event:
ESC Congress 2024
Topic:
Heart Failure
Session:
Antidiabetic drugs for treatment of cardiovascular disease
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
